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resumo As células estaminais mesenquimais (MSCs) são células estaminais adultas, 
multipotentes, capazes de se auto-renovar e diferenciar em diferentes tipos 
celulares mesodermais. O isolamento destas células pode ser feito a partir 
tecidos mesenquimais, bem como de extra embrionários, como por exemplo 
da matriz do cordão umbilical. Este último constitui uma fonte alternativa e 
atrativa de MSCs uma vez que estas apresentam características mais naïve e 
uma maior taxa de proliferação. 
In vivo, as células mesenquimais têm um microambiente especializado que é 
essencial à regulação da sinalização, proliferação, migração e diferenciação 
celular. Através da mecanotransdução, as forças mecânicas do ambiente 
extracelular são traduzidas em respostas bioquímicas que podem conduzir à 
alteração de fenótipo e diferenciação em diferentes tipos celulares e, além 
disso, à alteração da síntese de proteínas.  
A partir destas observações, este trabalho teve como objetivo o estudo do 
efeito das propriedades do substrato, tais como a rigidez e composição 
bioquímica, no secretoma e subproteomas de células estaminais mesenquimais 
isoladas a partir da matriz do cordão umbilical. Este estudo revelou uma 
modulação do secretoma e subproteomas celulares (frações solúvel e 
membranar) quando as MSCs foram mantidas em cultura sobre substratos com 
menor rigidez, demonstrando a modulação de múltiplas proteínas e 
nomeadamente o aumento dos níveis de proteínas anti-oxidantes. Deste 
modo, propomos que células cultivadas em substratos com menor rigidez 
possuam uma maior atividade anti-oxidante, o que irá permitir que estas 
apresentem uma melhor resposta face a ambientes hostis in vivo num contexto 
de transplantação. 

keywords Mesenchymal stem cells, Mechanotransduction, Stiffness, Secretome, 
subproteome 
abstract Mesenchymal stem cells (MSCs) are adult multipotent cells that possess self-
renewal capacity, have a high proliferative ability and are able to differentiate 
into mesodermal cell types. MSCs can be isolated from mesenchymal and 
extraembryonic tissues such as the umbilical cord matrix. The latter constitutes 
an attractive and alternative source of MSCs since these cells seem to be more 
naïve and possess higher proliferation capacity.  
In vivo, MSCs reside in a specialized microenvironment that is essential for the 
regulation of signaling, proliferation, migration and differentiation. Through 
mechanotransduction, mechanical forces of microenvironment are transduced 
into biochemical responses, which can lead to alterations in phenotype and 
lineage-specific differentiation, and changes in protein synthesis of MSCs. 
Based on these observations, this study aimed at exploring the effect of 
physical and biochemical substrate composition on the secretome and cellular 
subproteomes of MSCs derived from umbilical cord matrix. The present study 
revealed the modulation of the secretome and cellular subproteome profiles 
(soluble and membrane fractions) of MSCs cultured on soft substrates, with 
several proteins being modulated, namely the up-regulation of antioxidant 
proteins. Hence, we propose that MSCs cultured on soft substrates may 
constitute a population of cells with increased antioxidant properties, in 
principle allowing the cells to cope better with the stressful and hostile 
environments that they may encounter in vivo in a transplantation context. 
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1. INTRODUCTION
1.1. MESENCHYMAL STEM CELLS (MSCS) 
Mesenchymal stem cells (MSCs), also classified as mesenchymal stromal cells or mesenchymal 
progenitor cells, were first characterized by Friedenstein and colleagues1 as an adherent and 
fibroblast-like population of cells from the stromal compartment of bone marrow (BM). MSCs 
are multipotent adult stem cells known by their unique characteristics, such as their 
undifferentiated state and ability to self-renew, high proliferative capacity, formation of clonal 
cell populations due to their colony forming unit-fibroblast (CFU-F) capacity, and multilineage 
differentiation potential1–3. These cells can differentiate into mesoderm-type cells like 
osteocytes, chondrocytes and adipocytes and this capacity is crucial to define bona-fide 
MSCs2,4 . Recent studies report that MSCs are also capable to differentiate in vitro into non-
mesenchymal lineages, such as neural-like lineages5.   
1.2. SOURCES OF MESENCHYMAL STEM CELLS 
Bone marrow (BM) represents the primary and the most common source of MSCs1. However, 
this source involves an invasive isolation and the proliferative capacity and potential of 
differentiation decrease with donor’s age6,7, hence, alternative sources for isolating MSCs have 
been explored.  
Mesenchymal stem cells can be isolated from several adult tissues such as skeletal muscle, 
adipose tissue8, dental pulp and other dental tissues9.  
In addition, MSCs can be found in extra-embryonic tissues like the umbilical cord (UC) and 
umbilical cord blood (UCB), placenta and amniotic fluid10,11. Extra-embryonic tissues are a good 
alternative source of MSCs since these appear to be more naïve and possess higher 
multipotent plasticity, have lower immunogenicity12,13 and faster proliferation14 than MSCs from 
adult mesenchymal tissues. Besides that, extra-embryonic tissues have an early stage of 
development and possibly less incorporated mutations when compared with adult tissues15.  
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1.2.1. UMBILICAL CORD MATRIX – WHARTON’S JELLY (WJ) 
The umbilical cord (UC) is an extra-embryonic formation that contains two arteries, a vein and 
connective tissue that surrounds the vessels, named Wharton’s jelly (WJ)16. Wharton’s jelly is the major 
component of extracellular matrix of umbilical cord and a rich source of MSCs. It is largely composed 
by collagen and proteoglycans5,12 providing a natural microenvironment for MSCs, and has stromal 
support properties17.  Within the Wharton’s jelly, MSCs can be isolated from three different regions — 
perivascular, intervascular and subamnion —, representing different sub-populations of MSCs.  Besides 
UC tissue, umbilical cord blood (UCB) also contains MSCs18, although in much lower amounts. The 
currently existing techniques for harvesting and expanding UCB-MSCs are not robust enough to 
counterbalance the low frequency of these cells17.  All compartments of UC where MSCs can be found 
are represented in Figure 1.  
Since umbilical cord is considered medical waste, it is a non-controversial source and does not raise 
ethical problems for its collection. Furthermore, UC allows the isolation of a large initial number of 
cells, avoiding extensive proliferation and eventual genetic and epigenetic damage17 and cells are 
collected through a simple, non-invasive and painless process19.  
UC-MSCs share many properties with adult BM-MSC, including most of the typical MSCs 
immunophenotypic markers in common with BM-MSCs (Table 1).  
In addition, WJ’s-MSCs show higher proliferative capacity and shorter doubling population 
time, have higher CFU-F frequency and greater ex vivo expansion capacity5. WJ’s-MSCs are 
reported to possess some characteristics similar to embryonic stem cells (ESCs), including the 
potential of differentiate into cell types of the three germ layers3, the expression of stem cell 
markers such as Oct-4, Sox-2, and Nanog7,20, with the advantage that MSCs do not form 
teratomas upon transplantation17. Nevertheless, these similarities with ESCs are still 
controversial and the focus of ongoing research. However, UC-MSCs are considered a more 
primitive population. 
5 
Figure 1. Human Umbilical Cord (UC) section with distinct regions that contains mesenchymal stem cells. 
Umbilical Cord Blood (UCB); Wharton’s Jelly (includes Subamnion, Intervascular and Perivascular 
regions); and Umbilical vein subendothelium. Adapted from Troyer and Weiss, 200817. 
WJ-MSCs are CD73, CD90, CD105 and HLA class I positive, and CD45, CD34 and HLA class II 
negative10,21. These cells are also plastic-adherent and have fibroblast-like morphology when 
cultured in vitro. WJ-MSCs are multipotent (adipo-, chondro- and osteogenic potential), hence 
sharing all minimal criteria used to define MSCs as proposed by the Internal Society for Cellular 
Therapy22,23. Moreover, according to the literature, MSCs from WJ showed a higher 
therapeutic potential compared with other sources due to their immune-privileged nature, 
which could mean a reduced incidence of graft-versus-host disease, in transplantations17. 
WJ’s-MSCs also have higher proliferation rates, better immunomodulatory properties and 
longer maintenance of multipotent characteristics during time, in vitro22. 
Intervascular 
Region 
Subamnion 
Amnion 
Umbilical Cord Blood (UCB) 
Umbilical Cord Vein 
subendothelium 
Perivascular 
Region 
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Table 1. Surface marker expression of BM-MSCs and UC-MSCs (adapted from Anzalone et al., 201010). 
1.3. MECHANOTRANSDUCTION 
In vivo, cells reside in a specialized microenvironment that is essential for the regulation of signaling, 
proliferation, migration and differentiation24,25. This microenvironment consists of soluble and surface-
bound signaling factors, cell-cell contacts and the extracellular matrix (ECM), which is its major 
component25.  
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Through cell-ECM adhesion sites (multimeric protein complexes called Focal Adhesions — FAs), cells 
can sense and integrate (physiological) mechanical stimuli and convert them into intracellular signaling 
through mechanotransduction mechanisms. Hence, cells can sense and respond to complex 
biochemical and biophysical signals that will influence the cell’s behavior, morphology, dynamics, and 
fate25,26. Mechanotransduction has been showed to modulate lineage specification of MSCs by 
integrating the biochemical and biophysical properties of the ECM, triggering signal transduction 
cascades26, contributing to cell fate decisions in addition to other stimuli presented to cells, such as 
those provided by soluble factors. This modulation includes short-term responses, such as alterations 
in intracellular tension, adhesion, spreading or migration; as well as changes in long-term effects, such 
as protein synthesis and secretion, structural reorganization, proliferation and viability. In addition to 
FAs, a variety of molecules and subcellular structures have been shown to mediate force-sensing and 
mechanosignaling, such as primary cilia, cell-cell adhesions (such as Adherens Junctions), stretch-
modulated ion channels, the nucleus and the cytoskeleton27 (Figure 2). 
1.3.1. MECHANISMS OF MECHANOTRANSDUCTION  
The direct involvement of ECM in signal transduction through integrin receptors has been studied in 
order to understand how matrix elasticity influences cell behavior. Integrins mediate cell adhesion to 
the ECM and this creates a dynamic relationship whereby the ECM can transduce signals into the 
intracellular environment or, on the other hand, signaling from the cell can also change the ECM. Thus, 
integrin-mediated cell-ECM adhesions (Focal Adhesions) act as a bridge between the extracellular 
environment and the cellular cytoskeleton that contains the primary regulator of cellular traction forces 
— actin-myosin based contractility28.  
As introduced above, it is thought that cells sense and respond to biophysical signals through integrin-
mediated focal adhesion (FA) signaling (Figure 2). Focal adhesions are cell membrane regions involved 
in cellular attachment to ECM proteins (such as fibronectin, collagen or laminin) through 
transmembrane proteins named integrins. Thus, mechanotransduction initiates at focal adhesions by 
inducing local conformational changes, followed by signal transduction cascades inside the cytoplasm. 
Intracellular domains of integrins interact with adapter and signaling molecules such as talin, paxilin, 
vinculin and α-actinin allowing the direct physical linkage to the actin cytoskeleton25,27,29.  
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Figure 2. Biophysical signals and molecular interactions between cells and their microenvironment. 
Biophysical signals in cells niche include extracellular matrix (ECM) rigidity and topography, flow shear 
stress, strain forces, and other mechanical forces exerted by adjacent support cells. Fexternal and Fcell 
shows the balance of external and internal forces, respectively. Stem cells can sense these stimuli 
through mechanosensors such as ion channels, focal adhesions, cell surface receptors, actin 
cytoskeleton, and cell-cell adhesions, (Adapted from Sun et al., 201225). 
In response to mechanical stimuli, many enzymes change their kinetics, namely focal adhesion kinase 
(FAK) that once activate induces several signaling pathways30. This activation may regulate diverse cell 
functions such as migration, differentiation and proliferation. Additionally, FAK can also activate RhoA 
that is a key regulator of actin cytoskeleton tension. Active RhoA recruits myosin II to bind actin 
cytoskeleton, leading to an increase of cytoskeleton tension and FAs reinforcement by recruitment of 
further FA proteins. Sequentially, actomyosin cytoskeleton contracts which results in a retrograde 
movement of actin fibers. The stiffer the extracellular environment, the higher the tension transmitted 
to the nucleus through the LINC complex, which constitutes a protein complex physical bridge between 
the cytoskeleton and the nuclear lamina24,29,31. Hence, mechanical signals are transmitted to the 
nucleus and modulate the nuclear shape, — as well as the shape of the whole cell —, which may vary 
depending on tension forces sensed and exerted by cells. With increased tensile forces cells present a 
more elongated nucleus in contrast to a more round shape when low forces are acting31. Generally, 
more tension forces are related to increased stiffness of substrates, while low tension forces are related 
Actin cytoskeleton 
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to soft ones. This phenomenon reflects the reaction of cells to their environment, constantly probing 
the environment and responding according to the biophysical conditions that are present. 
1.3.2. STIFFNESS  
Several cell types, and in particular stem cells (including MSCs), are sensitive to ECM or substrate 
mechanics (when in vivo or in vitro, respectively), where distinct degrees of stiffness can drive their 
differentiation into specific lineages or, for instance, maintain stem cells in a pluripotent or multipotent 
state. Although the direct activation of signal transduction through integrin receptors by extracellular 
matrix proteins has been well studied32, the mechanisms through which physical properties of the ECM 
— such as stiffness — are transduced into the cells are still not fully understood.   
The stiffness of a material is measured by the ratio between applied forces and the resulting stretch. 
In a biological context, a material stiffness or elasticity is referred to as Young’s or Elastic modulus (E) 
and can be defined as ratio of force per unit area needed to deform a material by a given fractional 
amount without any permanent deformation. So, a high elastic modulus corresponds to high stiffness 
and low deformability36. To quantify the rigidity of a material, the Elastic modulus (E) and shear modulus 
(G) are commonly used. For the determination of the elastic modulus (E), the force is applied
perpendicularly to the material’s surface, while for shear modulus the applied force is parallel to the 
surface (Figure 3). The function E=2G (1+v), where v is the Poisson ration, relates elastic and shear 
modulus. In cases when materials do not change volume under stretch, the Poisson ratio is 0.5 and 
consequently the elastic modulus will be three times its shear modulus. The units for rigidity are force 
per unit area, the SI unit being Pascal (Pa), which in a biological context can be commonly represented 
as nN/µm2 or kPa30. 
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Figure 3. Shear and Elatic Moduli. Shear (G) and Elastic moduli (E) are the ratio of stress over strain. 
While stress is the amount of force applied per area (F/A), strain represents the displacement in the 
direction of the applied force relative to initial length (Δx/ΔL). The direction of the applied force differs 
on shear and elastic modulus. While for the elastic modulus (E), the force is applied perpendicularly to 
the material’s surface, for shear modulus the applied force is parallel to the surface. (Adapted from 
Moore et al., 201030). 
Tissues in the body exhibit different physical properties, namely stiffness. The elastic moduli of 
mammalian tissues (not being static) range from 0.1 nN/µm2 to 30,000,000 nN/µm2 (Table2). It may 
vary with age, as it is the case of brain (by decreasing), or during a pathology, including muscular 
dystrophies, cardiomyopathies or cancer progression and metastasis30,31. 
Table 2. Elastic modulus of several mammalian tissues. (Adapted from Moore et al., 201030). 
Usually cells reflect a more physiological-like behavior in vitro when cultured on materials with stiffness 
similar to their native microenvironment30. According to Engler et al., 2006 34,matrix elasticity has 
profound effects on the differentiation of mesenchymal stem cells. Soft matrices promote 
Tissue Type Elastic Modulus (nN/µm2) 
Brain 0.1-10 
Muscle 12-100 
Fat 20 
Artery 100-3,800
Areolar connective tissue 
(fibroblasts in collagen) 
600-1,000
Bone 17,100,000-28,900,000 
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differentiation into neuronal-like cells, moderate elasticity favor myogenic differentiation and rigid 
matrices leads cells to osteogenic differentiation 32,34 (Figure 4).  
Figure 4. Multiple factors regulating stem cell fate. Factors like secreted soluble factors; elasticity, 
biochemical composition and dimensionally of substrate have profound effect on mesenchymal stem 
cell differentiation. According to the literature, soft matrices favored neuronal-like cell differentiation, 
moderate elasticity promoted myogenic differentiation and rigid substrates stimulated osteogenic 
differentiation (Adapted from Even-Ram,S. et al., 200632). 
Assuming that cells are sensitive to biophysical signals encoded within the ECM, biomaterials can be 
used as a model to assess the effect of changing biochemical composition, topography or physical 
environment on cell behavior. One of the mechanical cues that can be investigated (by mimicking the 
ECM) is stiffness, which has been shown to have influence on cell proliferation, motility, stem cell 
differentiation and other cell functions. Nonetheless, stiffness responses depend on both the nature of 
the matrix and the cell-type specific components involved in the responses.  
1.4. PROTEOME AND SECRETOME OF MSCS 
The dynamic contact of cells with their niche has direct impact on cell phenotype and is a key regulator 
during proliferation and differentiation. The secreted molecules by MSCs are involved in intercellular 
communication and participate in many physiological processes, such as cell adhesion, binding and 
signaling, differentiation, invasion, metastasis, angiogenesis, and apoptosis; and contribute to the 
maintenance of homeostasis at the level of organs, systems or even the whole organism.  This complex 
set of secreted molecules is defined as Mesenchymal stem cell secretome35,36.   
The therapeutic potential of mesenchymal stem cells can be attributed to the fact that (i) these cells 
‘’home’’ or migrate to specific areas of acute injury via chemical gradients, (ii) act by local restoration 
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of function by differentiating into multiple cell types to augment or replace damaged tissues and (iii) 
therapeutic potential can be attributed to the secretion of bioactive factors with potential for affecting 
both local and systemic physiologic processes and tissue repair. Considering the latter, MSCs exert a 
therapeutic effect via secretion of bioactive factors with antiapoptotic, antiscarring and 
neovascularization effects, as well as immunomodulatory properties35. 
Park et al., 200736 provided a comprehensive compilation of human MSCs’ proteome. Some 
information such as extracellular matrix proteins and cytokines, chemokines and growth factors of 
MSCs36 is summarized in Figure 5, which is in agreement with other studies37.  
Figure 5. Extracellular matrix proteins, cytokines, chemokines, growth factors and receptors identified in 
WJ-MSCs by proteomics analysis. Seven types of collagen where identified in MSCs, as well as 
Fibronectin, Laminin, Vitronectin and Proteoglycans; relative to cytokines and chemokines, a large set 
of them are expressed by MSCs and seem to have important roles in regenerative medicine (Adapted 
from Park et al., 200736) 
Several studies have already analyzed Mesenchymal stem cells expressed proteins and the highly 
expressed proteins in MSCs can be grouped into several functional categories related with metabolism, 
developmental processes such as differentiation and proliferation, morphogenesis, extracellular matrix 
or cytoskeleton.A study reported a proteomics analysis of Wharton’s Jelly-derived MSCs. Overall, 60% 
of the total proteome was identified as proteins belonging to the cytoskeleton compartment and 
involved in protein biosynthesis, folding and degradation. This fact evidenced the proliferative capacity 
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of WJ-MSCs as well as the ability of rapidly change their phenotype in response to external stimuli38. A 
majority of the proteins belonging to ECM components or cytokines indicated that both the unique 
ECM environment and specific cytokine induction constitute important elements of the functional 
states of MSCs.  
 
1.4.1. EFFECT OF SECRETED MOLECULES BY MSCS 
 
The effects of MSC-secreted bioactive molecules can be either direct or indirect: direct effects activate 
intracellular signaling while indirect effects activate the secretion of molecules by other cells. MSCs also 
secrete a number of bioactive factors that directly suppress immune recognition and the expansion of 
B and T cells39. Mesenchymal stem cells are the most well-studied and well-understood cell type in the 
field of stem cell therapy and whose secretome has been most extensively investigated for therapeutic 
applications. So far, a variety of pro-inflammatory, anti-inflammatory and pleiotropic cytokines, 
chemokines, angiogenic factors, growth factors, growth factor-binding proteins, extracellular matrix 
proteins and extracellular matrix remodeling enzymes have been identified in mesenchymal stem cell 
secretomes. A number of angiogenic stimulators and inhibitors have been identified in MSCs secretome 
like vascular endothelial growth factor (VEGF), IL-6, fibroblast growth factor-2 (FGF-2) which secretion 
can be modified by chemokines. VEGF, TGF-β (transforming growth factor beta) and IL-6 are usually 
secreted by MSCs that have been recruited by tumor cells. Furthermore, it was reported that the 
secretome collected from MSCs populations may induce differentiation into different neuronal 
phenotypes40.Thus, stem cell secretome represents a novel, promising alternative or complement to 
cell-based regenerative medicine therapies.  
Overall, it has been shown that MSCs secretome varies depending on the microenvironment. 
Eventually, the proteome of MSCs could also vary depending on the external stimuli sensed by cells.  In 
the case of a pathology, MSCs secrete a range of different molecules; and cells under specific conditions 
are able to escape from their original fate41. When physical properties of the microenvironment 
change, such as stiffness, MSCs secretome seems to suffer some alterations. Previous reports42 showed 
an enhancement of secretion of paracrine factors when cytoskeletal tension increased. Dynamic MSCs 
studies have been conducted in order to elucidate about the molecular interplay between contractile 
apparatus and physical/biochemical stimuli sensed and integrated by MSCs and how it can affect their 
secretory and proteomic profile. Nevertheless, the issue of how mechanical cues affect the secretome 
and/or the overall proteome of MSCs remains very poorly explored. 
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1.5. OBJECTIVES  
 
Mesenchymal stem cells are of great interest in clinical studies, since they can be readily isolated and 
expanded, exhibit multi-lineage differentiation potential and are known to secrete several bioactive 
molecules. 
Some studies suggest that MSCs response to alterations of physical properties of their environment by 
changing marker expression and secretion of molecules.  
We proposed that by using distinct cell culture substrates — namely using softer or stiffer materials, 
associated with ECM proteins —, the secretome of MSCs may suffer modifications, as well as the 
protein composition found in the membrane and cytoplasmic fractions. 
Globally, this project aimed to understand how mechanotransduction elements influence the 
proteome (secretome, membrane and cytosolic proteomes) of WJ mesenchymal stem cells. 
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2. MATERIALS AND METHODS 
2.1. UMBILICAL CORD (UC) SAMPLES PROCESSING AND CRYOPRESERVATION 
 
2.1.1. UMBILICAL CORD (UC) TISSUE PROCESSING 
  
Fresh human umbilical cords (UCs) were obtained from Crioestaminal, S.A. (BiocantPark, Cantanhede, 
Portugal) after informed consent of the donors. Biological samples were always manipulated under 
aseptic conditions using a class-II biosafety cabinet (Thermo Heraeus KS12). Samples were stored at 
4°C, in sterile 50 mL conical tubes (Orange) with antibiotics for 48h at maximum, before tissue 
processing. Each umbilical cord sample was washed with sterile phosphate buffered saline solution 
(PBS, Life Technologies) to remove blood. Then, the samples were cut with a scissor into sections of 
about 5 cm long. The sections were washed and a longitudinal section was made in order to remove 
the vein and arteries to avoid endothelial cell contamination and obtain only cells from the region of 
interest — the Wharton’s Jelly. Once obtained, Wharton’s jelly was cut into 2-5 mm fragments with the 
help of a scalpel and tissue dissection tweezers and forceps.  
 
2.1.2. CRYOPRESERVATION OF WHARTON’S JELLY FRAGMENTS  
 
Fragments of Wharton’s jelly were collected to cryopreservation vials with a forceps and it was added 
1 mL of freezing medium [composed of Fetal Bovine Serum — FBS (Life Technologies) supplemented 
with 10% (v/v) of Dimethyl Sulfoxide — DMSO (Sigma-Aldrich)]. The vials were frozen overnight at -
80°C in a cryo-cooler (VWR) and then transferred to a liquid nitrogen cryotank (Statebourne).  
 
2.2. PREPARATION OF CELL CULTURE SUBSTRATES 
 
2.2.1. PRODUCTION OF POLYDIMETHYLSILOXANE (PDMS) HYDROGELS  
 
PDMS, a silicon elastomer, was used to produce substrates with tunable mechanical properties and 
tissue-like stiffness43. Crosslinked networks of PDMS were prepared by mixing the silicon elastomer 
base and the curing agent (Sylgard 184; Dow corning, USA). Two different mass ratios of base 
elastomer: curing agent were produced; 10:1 and 40:1. For each mixture, 1 mL was poured into 21 cm2 
plates to create approximately 200 µm thick hydrogels for cell culture. All PDMS substrates were left 
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to degas using a vacuum apparatus (Vacusafe, Integra Biosciences) at room temperature (RT) for 40 
minutes to remove air bubbles. Thereafter, PDMS was cured at 70°C for 4 hours in an incubator 
(Binder).   
2.2.2. TREATMENT OF PDMS HYDROGELS  
Since native PDMS surface limits cell adhesion due to high hydrophobic surface properties, cured PDMS 
hydrogels were chemically treated (as described below). The goal was to modify the PDMS surface in 
order to establish a more hydrophilic surface and to allow the establishment of covalent links between 
ECM proteins and the PDMS surface43,44, mimicking an in vivo cellular microenvironment, in order to 
facilitate cell adhesion and proliferation. 
One drawback of PDMS substrates is putative surface roughness, which can negatively influence the 
efficiency of the treatment and cell adhesion (REF). In order to increase the efficiency of surface 
modification and diminish roughness, 10:1 substrates were detached from the plate and the polished 
surface (the one that polymerized in contact with the bottom of the plate) was exposed to the chemical 
treatment before further functionalization. 40:1 substrates were less hydrophobic and did not show 
problems in terms of cell adhesion, hence the upper surface of the substrate was directly treated and 
functionalized. 
The chemical treatment consisted of adding three different solutions to PDMS substrates: Solution 1- 
hydrogen peroxide (H2O2, Sigma), Hydrochloric Acid (HCl, Fluka) and miliQ water (mQ water); Solution 
2- 10% (v/v) of 3-aminopropyltrimethoxisilane (3-APTMS, Alpha Aesar) in 96% (v/v) ethanol (EtOH,
Merck); Solution 3- 3% (v/v) glutaraldehyde in PBS. 
First, PDMS substrates were treated with solution 1. 10:1 substrates were treated with solution 1 in a 
volumetric proportion of 1:1:3 and 40:1 substrates were treated with the same solution in a volumetric 
proportion of 1:1:5. The reaction occurred during 5 minutes at RT and allowed the formation of silanol 
groups on the surface of PDMS (hence the surface became more hydrophilic). The need for different 
volumetric proportions of solution 1 lies in the fact that 10:1 substrates showed higher hydrophobicity 
and required a more concentrated H2O2:HCl solution. Next, all substrates were washed three times 
with abundant mQ water and treated with solution 2 during 30 minutes at RT (the silane groups of 3-
APTMS reacted with the silanol groups on the PDMS surface, hence establishing covalent links)43. 
Afterwards, the hydrogels were washed three times with mQ water, 10 minutes each time with 
agitation. The last solution - solution 3 – was added and the reaction occurred during 20 minutes at RT. 
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The aldehyde (–CHO) functional groups of glutaraldehyde readily react with the amine (–NH2) groups 
of 3-APTMS and provided strong covalent bonds, enabling the subsequent modification steps (2.2.3). 
Next, the plates were washed three times with agitation during 5 minutes each. The washes during the 
treatment are required to remove remaining reagents that could possibly compromise the subsequent 
reactions and threat cell culture.  Once functionalized, substrates were exposed to ultra violet (UV) 
light for 30 minutes in an air flow cabinet to ensure sterilization. 
2.2.3. CROSSLINKING OF ECM PROTEINS ON PDMS HYDROGELS 
In vivo, the extracellular matrix (ECM) plays essential roles in cell behavior and development. According 
to the objectives of the present study, to culture stem cells on PDMS substrates, it is necessary to mimic 
the extracellular matrix.  
For that end, a mixture of two of major structural proteins composing ECM, in vivo, was applied on 
PDMS hydrogels in order to coat its surface and allow cell adhesion45. Human plasma purified 
Fibronectin (FN) and rat tail type I Collagen, (both from Millipore) were mixed in PBS at a final 
concentration of 10 µg/ml and 17 µg/ml, respectively- Coating Solution. The coating solution containing 
FN and collagen was used to coat the functionalized PDMS substrates at a ratio of 143 µl per cm2 of 
substrate surface, resulting in 1.4 µg/cm2 of FN and 2.4 µg/cm2 of collagen. Hydrogels were incubated 
with Coating Solution at 37°C for 3 hours, and then washed once with sterile PBS.  
2.3. ISOLATION, EXPANSION AND CRYOPRESERVATION OF MSCS 
2.3.1. ISOLATION AND CULTURE EXPANSION OF MESENCHYMAL STEM CELLS (MSCS) BY EXPLANT METHOD  
To proceed to explant culture method, fragments were thawed at 37ᵒ C and washed with Alpha-MEM 
medium (Life Technologies) supplemented with 1% Penicillin/Streptomycin (Life Technologies) and 1% 
amphotericin B (Life Technologies). Groups of 30 fragments were transferred to 21 cm2 tissue culture 
(TC) plate (Corning) and to 21 cm2 PDMS hydrogel and left to dry for 30 minutes to promote the 
attachment of the fragments to the surface of the plate and hydrogel, respectively. When fragments 
attached, 6 mL of proliferation medium - Alpha-MEM (Life Technologies) supplemented with 10% (v/v) 
MSC-qualified Fetal Bovine Serum (FBS) (Hyclone), 1% (v/v) Penicillin/Streptomycin (Life Technologies) 
and 1% (v/v) amphotericin B (Life Technologies) - were added to culture plates/hydrogels. Once 
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fragments were immersed, they were incubated at 37ᵒC with 5% of CO2/95% air and 95% humidity 
until MSCs started migrating out of the umbilical cord fragments. After 10 days it was possible to 
observe first cells migrating. Fragments were kept in culture until well-defined colonies were obtained. 
Then, the fragments were removed and the cells were detached and seeded into new 21cm2 TC plates 
or hydrogels, respectively, to homogenize the population of cells.    
2.4. PASSAGING AND FREEZING 
For the passaging and freezing procedures cells were washed twice with sterile PBS and detached with 
0.05% (v/v) Trypsin-EDTA (Life Technologies) during 5 minutes at 37ᵒ C. Then, it was added Alpha-MEM 
supplemented with 10% (v/v) FBS (Life Technologies), 1% (v/v) Penicillin/ and 1% (v/v) Amphotericin B 
to inactivate trypsin and cells were collected to a conical centrifuge tube. Then followed a 
centrifugation (5810 R centrifuge, Eppendorf) at 290g, 22ᵒ C for 5 minutes. Afterwards, for passaging 
procedure, pellet was re-suspended with proliferation medium with the help of a serological pipette 
(Corning-Costar) and plated on a new TC plate at a density of 3,000 cells/cm2. Cells were kept in an 
incubator (Binder C-150) at 37ᵒ C with 5% of CO2/95% air and 95% humidity until reach 80% of 
confluence. For freezing procedure, after centrifugation, pellet was re-suspended in 1 mL of FBS with 
10% (v/v) DMSO and collected to a cryo-vial.  The vials were frozen overnight at -80ᵒ C in a cryo-cooler 
and then transferred to a nitrogen cryotank.  
2.5. PROLIFERATION KINETICS OF UC- MSCS 
MSCs isolated from three independent cord samples were cultured in 21 cm2 plates and PDMS 
hydrogels. Cells were cultured from P2 to P6 and counted once they reached 80% confluence at each 
passage. Initially, fragments of UCs were cultured in 21 cm2 TC plates (P0) and homogenized in the 
same type of plates- Passage 1 (P1). At passage 2, homogenous populations of cells were transferred 
to 21 cm2 TC plates and 21 cm2 PDMS hydrogels (10:1 and 40:1) in a density of 3,000 cells/cm2.  Cells 
isolated on PDMS substrates were not part of kinetic study. Kinetic study was only applied to cells 
isolated on TCPS and then cultured on TCPS and transferred to 40:1 PDMS gels.    
The population doubling (PD) rate was calculated at each passage using the equation NH/NI=2X, or [log10 
(NH) — log10 (NI)]/log10 (2) =X, where NI represents the number of cells plated at each passage, NH the 
number of cells harvested at the end of each respective passage and X the population doubling (PD). 
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The PD for each passage was calculated and added to the PD of the previous passages to generate 
cumulative population doublings (CPD). In addition, the generation time (GT) – average time between 
two cell doublings — was calculated from P3 to P6 using the following formula: X = [log10 (2) x Δt]/ [log10 
(NH) — log10 (NI)]. The total number of cells (TNC) was determined at each passage by cumulative 
counting of the cells once they reached a confluence of 80%, using the formula: X = NH x B/NI, in which 
B represents the total number of cells in the previous passage. TNC accounts for the theoretical number 
of cells that could be obtained if no cells were discarded between each passage46.   
2.6. IMMUNOPHENOTYPIC CHARACTERIZATION OF UCM-MSCS 
The immunophenotypic characterization of MSCs was performed before in collaboration with Centro 
Hospitalar da Universidade de Coimbra – Unidade de Gestão Operacional de Citometria. The 
immunophenotypic step was performed prior to cell culture. Cells were detached with accutase 
(LifeTechnologies) and the cell pellet was stained with monoclonal antibody (mAb) for surface protein 
antigens and, after an incubation period of 10 minutes in the darkness at room temperature (RT), 
washed with PBS. Then, cells were ressuspended in 250µL of PBS and immediately acquired in a 
FACSCanto II (BD) flow cytometer. The mAb used were conjugated with the following fluorochromes: 
fluorescein isothiocyanate (FITC), allophycocyanin (APC), phycoerythrin (PE), phycoerythrin-cyanine 7 
(PECy7), krome orange (KO) and phycoerythrin-cyanine 5 (PerCPCy 5.5) The following monoclonal 
antibodies were used for the labelling: CD105 FITC (clone 2H6F11, Immunostep), CD90 APC (clone 
5E10, BD Pharminogen), CD73 PE (clone AD2, BD Pharminogen), CD13 PECy7 (clone Immu103.44, 
Beckman Coulter), CD45 KO (clone J.33, Beckman Coulter) and CD34 PerCPCy 5.5 (clone 581, BD 
Biosciences).  
2.7. MULTIPLEX CYTOKINE ANALYSIS 
In order to analyze the concentration of cytokines on MSCs’ conditioned media, an antibody-based 
multiplex analysis was performed using a Bio-Plex Pro 8-Plex Panel Assay (Bio-Rad, Hercules, CA, USA), 
according to the manufacturer’s instructions and as detailed below, using a Bio-Plex 200 system (Bio-
Rad). The 8-plex panel evaluated the presence of the following analytes: GM-CSF, IFN-γ, IL-2, IL-4, IL-6, 
IL-8, IL-10 and TNF-α. 
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Conditioned media were obtained as described in II.8, except that after the 48h conditioning, media 
were collected (at least 100 µL of medium from each condition was obtained) and immediately 
centrifuged (at 290g, 4ᵒC, for 5 minutes) to remove cell debris. Samples were frozen at -80°C until the 
analysis was performed Conditioned media were collected and centrifuged (290g, 4ᵒ C for 5 minutes) 
and 100 µL of medium of each platform was used to perform the assay.    
 Samples were thawed on ice and homogenized using a microplate agitator and then processed as 
follows (according to the kit’s instructions). Samples were incubated at RT with agitation with the 
antibody-conjugated beads for 1 hour and then washed three times using the kit’s Wash Buffer, 
followed by vacuum aspiration. The incubation with detection antibodies was performed for 30 min 
(RT) with agitation, followed by three washes as before. Finally, the incubation with the antibody 
conjugate streptavidin-phycoerythrin (SA-PE) was performed for 10 min (RT, with agitation), followed 
by three washes/aspiration cycles. The beads were re-suspended with Assay Buffer and data was 
acquired using a Bio-Plex 200 system. Acquisition and analysis was performed using the software Bio-
Plex Manager 5 (BioRad). 
2.8. SECRETOME AND SUBCELLULAR PROTEOME ANALYSIS 
To proceed to secretome collection and subproteome fractionation, 3 million cells were seeded on 2 
different platforms — TCPS (tissues culture plates) and 40:1 PDMS hydrogels — at a density of 6, 000 
cells/cm2. Cells were incubated at 37ᵒ C with 5% of CO2/95% air and 95% humidity with proliferation 
medium until reaching approximately 50% of confluence. Next, the medium was discarded, cells were 
washed twice with PBS and once with Alpha-MEM supplemented with antibiotics to remove the 
remaining FBS from proliferation medium. Finally, to obtain conditioned medium, Alpha-MEM 
supplemented with antibiotics was added to the cells and incubated for 48 hours (using a CO2 incubator 
as described above). 
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2.8.1 SECRETOME COLLECTION 
After 48 hours of media conditioning, 100 mL of medium were collected from each platform and 
centrifuged at 290g, for 5 minutes at 4°C to remove cell debris. Then the secretome was concentrated 
using cut-off filters of 5 kDa (Vivaspin20, Sartorius) until 1 mL of concentrated conditioned media was 
obtained. The concentrated conditioned media were precipitated using Trichloroacetic acid (TCA) - 
Acetone. TCA was added to each sample to a final concentration of 20% (v/v), followed by an incubation 
at -80⁰C and centrifugation at 20,000g for 20 minutes. Protein pellets were washed with ice-cold (-
20°C) acetone, the pellets were solubilized in acetone, aided by ultrasonication, followed by a 
centrifugation at 20,000g for 20 minutes. The washed pellets were re-suspended in 2× Laemmli buffer 
(BioRad), aided by ultrasonication and denaturation at 95°C for 5min. 
2.8.2. SUB-CELLULAR FRACTIONATION  
To obtain cellular extracts, cells were washed with PBS and then incubated with extraction buffer 
(50mM Tris-HCl buffer pH 7.4 with protease inhibitors — Protease Inhibitor Cocktail tablets, Complete 
EDTA-free, from Roche). Next, cells were subjected to ultrasonication in water-bath (VibraCell 750 
watts, Sonics®) with 40% amplitude with 30 second cycles (one second on followed by one second off 
and used for all procedures). After a 5 minutes centrifugation step at 4°C , 1,000g the supernatant was 
centrifuged at 126,000g at 4°C for 1 hour (Beckman Coulter)47, and the pellet corresponding to the 
membrane-enriched fraction was solubilised in SDS sample buffer (1.7% SDS and 100mM DTT in 50mM 
Tris buffer at pH 6.8)48. Five volumes of -20°C acetone were added to each soluble fraction and were 
stored at -20°C to precipitate the protein content, which was then recovered by centrifugation at 
4,000g for 30 minutes at 4°C and the protein pellets were washed with ice-cold (-20°C) acetone. 
Afterwards the pellet correspondent to the soluble fraction was re-suspended in SDS sample buffer 
49,50. Protein quantity was assessed using the Direct Detect Spectrometer (Milipore) according to the 
manufacturer’s instructions, and 100 µg or the total amount protein (soluble or membrane fraction, 
respectively) were used from for LC-MS/MS analysis.  
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2.8.3. IN GEL DIGESTION AND SAMPLE PREPARATION 
After denaturation, samples were alkylated with acrylamide and subjected to in gel digestion by using 
the short-GeLC approach51. Briefly, the entire sample was loaded in a “4–20% TGX Stain-Free Gel” (Bio-
Rad) and subjected to a partially electrophoretic separation: 15 min at 110 V to allow the samples to 
enter into the gel. After SDS-PAGE proteins were visualized with Colloidal Coomassie Blue and the 
staining was performed as previously described in the work of Candiano and co-workers52 with slight 
modifications47.  
The entire lanes were sliced into 3 parts and each part was sliced in small pieces and processed. Gel 
pieces were destained using the destaining solution (50 mM ammonium bicarbonate and 30% 
acetonitrile) followed by a washing step with water. Gel pieces were dehydrated on Concentrator 
Plus/Vacufuge® Plus (Eppendorf). Eighty (80) µL of trypsin (0.01 µg/µL solution in 10 mM ammonium 
bicarbonate) were added to the dried gel bands and left for 15 min, on ice, to rehydrate de gel pieces, 
after this period 25 µL of 10 mM ammonium bicarbonate were added and in-gel digestion was 
performed overnight at room temperature in the dark. After the digestion, the excess solution from 
gel pieces were collected to a low binding microcentrifuge tube (LoBind®, Eppendorf) and peptides 
were extracted from the gel pieces by sequential addition of three solutions of acetonitrile (ACN) in 1% 
formic acid (FA) (30%, 50%, and 98% of ACN, respectively). After the addition of each solution, the 
tubes were shaken in the thermomixer (Eppendorf) at 1050 rpm for 15 min and the solution was 
collected to the tube containing the previous fraction. The peptides mixtures were dried (preferentially 
not completely) by rotary evaporation under vacuum. 
Before performing the LC-MS/MS analysis the peptide mixtures were subjected to SPE (solid-phase 
extraction) using OMIX tips with C18 stationary phase (Agilent Technologies) as recommended by the 
manufacture. Eluates were dried by rotator evaporation, avoiding to totally evaporate the samples and 
peptides mixtures were re-suspended to 30 µL in a solution of 2% ACN and 0.1% FA followed by vortex, 
spin and sonication in water bath (2 min with pulses of 1 second – 1 s sonication followed by 1 s break 
pulse –, at 20% intensity, in a sonicator VibraCell 750 watts, Sonics®). In order to remove insoluble 
material the peptide mixture was then centrifuged for 5 min at 14,000g and collected into the proper 
vial for LC-MS analysis. 
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2.8.4. SWATH ACQUISITION 
Samples were analyzed on a Triple TOFTM 5600 System (ABSciex®) in two phases: information-
dependent acquisition (IDA) was followed by SWATH (Sequential Windowed data independent 
Acquisition of the Total High-resolution Mass Spectra) acquisition on the same sample. Peptides were 
resolved by liquid chromatography (nanoLC Ultra 2D, Eksigent®) on a MicroLC column ChromXPTM 
C18AR (300 μm ID × 15cm length, 3 μm particles, 120 Å pore size, Eksigent®) at 5μL/min. Peptides were 
eluted into the mass spectrometer with an acetonitrile gradient in 0.1% FA (5% to 35% ACN, in a linear 
gradient for 45 min), using an electrospray ionization source (DuoSprayTM Source, ABSciex®). 
Information dependent acquisition (IDA) experiments were performed for each 3 peptides mixtures of 
the pooled samples composed by the combination of the biological replicates of each condition.  The 
mass spectrometer was set to scanning full spectra (350-1250 m/z) for 250ms, followed by up to 60 
MS/MS scans (100–1500 m/z from a dynamic accumulation time – minimum 50 ms for precursor above 
the intensity threshold of 1000  – in order to maintain a cycle time of 3.3 s). Candidate ions with a 
charge state between +2 and +5 and counts above a minimum threshold of 10 counts per second were 
isolated for fragmentation and one MS/MS spectra was collected before adding those ions to the 
exclusion list for 25 seconds (mass spectrometer operated by Analyst® TF 1.6, ABSciex®). Rolling 
collision was used with a collision energy spread of 5. Peptide identification and library generation were 
performed with Protein Pilot software (v5.0, ABSciex®), using the following parameters: i) search 
against a database composed by Homo sapiens from SwissProt, and malE-GFP; ii) acrylamide alkylated 
cysteines as fixed modification; iii) trypsin as digestion type. An independent False Discovery Rate (FDR) 
analysis using the target-decoy approach provided with Protein Pilot software was used to assess the 
quality of the identifications and positive identifications were considered when identified proteins and 
peptides reached a 5% local FDR51,53.  
A single analysis of each sample was set for quantitative analysis by acquisition in SWATH mode. For 
SWATH-MS based experiments, the mass spectrometer was operated in a looped product ion mode 
[6] and the same chromatographic conditions used as in the IDA run described above. The SWATH-MS
setup was designed specifically for the samples to be analyzed, to that a pool of all samples was 
analyzed in IDA mode in order to be used to create to adapt the SWATH windows to the complexity of 
the set of samples to be analyzed. A set of 60 windows of variable width (containing 1 m/z for the 
window overlap) was constructed covering the precursor mass range of 350-1250 m/z. A 200 ms survey 
scan (350-1500 m/z) was acquired at the beginning of each cycle for instrument calibration and SWATH 
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MS/MS spectra were collected from 100–1500 m/z for 50 ms resulting in a cycle time of 3.25 s from 
the precursors ranging from 350 to 1250 m/z. The collision energy for each window was determined 
according to the calculation for a charge +2 ion centered upon the window with a collision energy 
spread of 15. 
A specific library of precursor masses and fragment ions was created for each sample type (secretome, 
membrane and soluble fractions) by combining the TCPS and PDMS files from the IDA experiments, 
and used for subsequent SWATH processing. Libraries were obtained using Protein PilotTM software 
(v5.0, ABSciex®) with the same parameters as described above.  
Data processing was performed using SWATHTM processing plug-in for PeakViewTM (v2.0.01, ABSciex®), 
briefly peptides were selected automatically from the library using the following criteria: (i) the unique 
peptides for a specific targeted protein were ranked by the intensity of the precursor ion from the IDA 
analysis as estimated by the ProteinPilotTM software, and (ii) Peptides that contained biological 
modifications and/or were shared between different protein entries/isoforms were excluded from 
selection. Up to 15 peptides were chosen per protein, and SWATHTM quantitation was attempted for 
all proteins in library file that were identified below 5% local FDR from ProteinPilotTM searches. In 
SWATH™ Acquisition data, peptides are confirmed by finding and scoring peak groups, which are a set 
of fragment ions for the peptide. 
Target fragment ions, up to 5, were automatically selected and peak groups were scored following the 
criteria described in Lambert et al54. Peak group confidence threshold was determined based on a FDR 
analysis using the target-decoy approach and 1% extraction FDR threshold was used for all the analyses. 
Peptide that met the 1% FDR threshold in at least one samples were retained, and the peak areas of 
the target fragment ions of those peptides were extracted across the experiments using an extracted-
ion chromatogram (XIC) window adapted for each set of sample:  3 min in the case of the samples from 
the soluble fraction, and 4 and 5 minutes for membrane and secretome samples, respectively.   
The levels of the human proteins were estimated by summing all the transitions from all the peptides 
for a given protein (an adaptation of55) followed by two steps of data normalization: (1) normalized to 
the internal standard (malE-GFP) followed by (2) a normalization using the sample total intensity. 
2.8.5. BIOINFORMATIC TOOL FOR DATA ANALYSIS 
PANTHER Classification System (http://www.pantherdb.org/) was performed for Gene 
Ontology analysis. GeneOntology enrichment analysis was performed for proteins identified 
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using the web-based application Gene Ontology enRIchment anaLysis and visuaLizAtion tool – 
GOrilla (http://cbl-gorilla.cs.technion.ac.il/). In order to identify and collect information about 
the proteins that were found, UniProt (http://www.uniprot.org/) was used. Venn graph were 
generate by BioVenn web application (http://www.cmbi.ru.nl/cdd/biovenn/).  
2.9. STATISTICAL ANALYSIS 
Statistical analysis of kinetitcs proliferation and multiplex-cytokine assay was performed by Mann-
Whitney test, where statistically significant differences are indicated (*P<0.05) using the software 
GraphPad Prism 6. 
Proteomics data was presented as the mean fold change of PDMS over the respective TCPS sample for 
the 3 biological replicates (umbilical cords from 3 different donors). Statistical analysis was performed 
in IBM® SPSS® Statistics Version 22 for all the proteins that presented PDMS/TCPS ratios with 
coefficient of variation below 30%. Data normality was accessed by the Shapiro-Wilk test performed in 
InfernoRDN and a one sample t-student test against a theoretical value of 1 was used to test for 
statistical meaningful variations. Statistical significance was considered for p-value<0.05.
CHAPTER 3 
RESULTS
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3. RESULTS
3.1. POLYDIMETHYLSILOXANE (PDMS) HYDROGELS FUNCTIONALIZATION 
Cell adhesion and its relationship with the substrate is usually influenced by the substrate properties, 
such as biomolecular/biochemical composition and rigidity. Cell interactions with ECM proteins are vital 
to many biological processes and matrix proteins have been used for coating substrates for in vitro cell 
culture. Proteins such as FN and collagen have an important role on cell adhesion and ECM-cell 
contacts56. Moreover matrix rigidity also influences cell behavior. PDMS has been used in cell culture 
due to its properties: it is a biocompatible substrate, therefore it can be used for long-term cell culture, 
and its tunable properties allow to mimic different in vivo conditions. 
Hence, PDMS hydrogels were fabricated as described (2.2.1), chemically functionalized (2.2.2) and 
covalently conjugated with ECM proteins (fibronectin and collagen I). The effectiveness of the developed 
biocompatible substrate could be demonstrated by cell adhesion and proliferation identified by phase-
contrast microscopy (Figure 6).  
Figure 6. MSCs in culture on two distinct substrates. (A) 40:1 PDMS and (B) TCPS at day 4. (A) Phase-
contrast microscopy images (5X objective) representative of the effectiveness of chemical modification 
of PDMS surface as well as of the coating proteins. Scale bar corresponds to 100 µm.  
B A 
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3.2. ISOLATION AND CULTURE EXPANSION OF MESENCHYMAL STEM CELLS (MSCS) BY THE EXPLANT 
METHOD 
Mesenchymal Stem Cells (MSCs) can be isolated from several tissues. However, due to their high 
frequency in the Umbilical Cord (UC), more specifically, in the Wharton’s Jelly, the latter constitutes a 
promising alternative source of MSCs once the process of MSCs collection from this tissue is simple, 
painless and non-invasive. Additionally, UC is discarded after birth and it does not raise many ethical 
constrains when compared with other sources. These tissues have also a low probability of viral 
contamination and the existence of public and private banks makes them more accessible for further 
use in heterologous and autologous transplants.  
3.2.1. ISOLATION AND CULTURE OF MESENCHYMAL STEM CELLS ON DISTINCT SUBSTRATES (TCPS AND 40:1 
PDMS) 
Human MSCs were isolated from three umbilical cords, as described in the Materials and Methods 
section. At the end of 10 days in culture, fragments of Wharton’s Jelly were still attached to the culture 
plates and showed cells migrating from the tissue. Fragments cultured on PDMS substrates (10:1 and 
40:1) showed first cells migrating after 15 days in culture. Colonies of cells displaying a MSCs-like 
phenotype and with spindle-shaped morphology could be identified by phase-contrast microscopy 
(Figure 7).  
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Figure 7. Wharton's Jelly explants culture and MSC-like cells migration. Phase-contrast microscopy images 
(5X objective) representative of MSCs isolated on (A), (B) TCPS; (C),(D) 10:1 PDMS; (E),(F) 40:1 PDMS. Left 
images – (A), (C) and (E) represent first cells migrating out of the explants while (B), (D) and (F) represent 
well defined colonies. 
F E 
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The cells cultured on TCPS formed compact colonies by the end of 14-16 days in vitro, while cells cultured 
on 10:1 and 40:1 PDMS substrates only formed compact colonies after 20 days in culture. Then the cells 
were dissociated using trypsin and reseeded on their respective substrate rigidity to homogenize the 
population (P1). After the first passage, the cells were constituted by a homogeneous population with 
MSC-like morphology. Cells isolated on both PDMS substrates (10:1 and 40:1) were cryopreserved. The 
cells cultured on TCPS were expanded on TCPS and 40:1 substrates from passage 2 until passage 6.  
3.3. IMMUNOPHENOTYPIC CHARACTERIZATION OF UC-MSCS 
Flow cytometry analysis demonstrated that the cells isolated from the WJ were positive for CD13, CD73, 
CD90 and CD 105 and negative for CD34 and CD45. This analysis (Figure 8) confirmed that cells isolated 
from Wharton’s Jelly region presented the minimal criteria to be defined as MSCs according to the 
International Society for cellular Therapy23 . 
Figure 8. Representative immunophenotype of Wharton’s Jelly MSCs. Cells were labeled with 
antibodies (as indicated) and analyzed by flow cytometry. Labeled MSCs (blue) showed positive 
expression of CD13, CD73, CD90 and CD105 and negative expression of CD34 and CD45. In green 
are represented the histograms of unlabeled cells. 
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3.4. PROLIFERATION KINETICS OF UC-MSCS 
As indicated before, MSCs were isolated and cultured on TCPS and at Passage 2 (P2) they were 
transferred to 40:1 PDMS substrates in parallel to TCPS. MSCs were cultured at the same time on both 
substrates and their growth kinetics was analyzed as depicted on Figure 9.  
 As referred on the Materials and Methods section (2.5) the population doubling (PD) rate was calculated 
at each passage using the equation NH/NI=2X, or [log10 (NH) — log10 (NI)]/log10 (2) =X, where NI represents 
the number of cells plated at each passage, NH the number of cells harvested at the end of each 
respective passage and X the population doubling (PD). The PD for each passage was calculated and 
added to the PD of the previous passages to generate cumulative population doublings (CPD). In 
addition, the generation time (GT) – average time between two cell doublings — was calculated from P3 
to P6 using the following formula: X = [log10 (2) x Δt]/ [log10 (NH) — log10 (NI)]. The total number of cells 
(TNC) was determined at each passage by cumulative counting of the cells once they reached a 
confluence of 80%, using the formula: X = NH x B/NI, in which B represents the total number of cells in 
the previous passage. TNC accounts for the theoretical number of cells that could be obtained if no cells 
were discarded between each passage46.   
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Figure 9. Proliferation kinetics of UC-MSCs cultured on two distinct substrates. Cells were passaged and 
counted once they reached around 80% confluence and the (A) population doubling (PD) was 
determined. (B) Cumulative population doubling (CPD) was determined by adding the calculated PD to 
PD of the previous passages; (C) Generation time (GT).  (D) Total number of cells of each passage was 
calculated, during 6 passages or (E), (F) over the time. Bars represent mean ± SEM of at least three 
independent experiments using cells obtained from different donors. Statistical analysis was performed 
by Mann-Whitney test using the software GraphPad Prism 6. Statistically significant differences are 
indicated (*P<0.05 ). 
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As observed in Figure 9, between passage 3 and 6 (P3-P6), TCPS samples had, on average, doubled the 
population 9.81 ± 1.58 (SEM) times during which the generation time ranged from 1.88 ± 0.32 (SEM) to 
3.27 ± 1.23 (SD) days. During the same passages, PDMS substrates had doubled the population on 
average 6.68 ± 1.48 (SEM) times with generation time varying from 1.95 ± 0.07 (SEM) to 4.65 ± 1.75 
(SEM) days. The total number of cells (TNC) could be evaluated from passage 2 since this parameter does 
not need previous information. This value corresponds to the total number of cells that could be 
obtained if no cells were discarded during these passages, 26 days for TCPS, was 1.61 ×1010 ± 1.12 × 1010 
(SEM). For 40:1 substrates, the total number of cells was 1.37× 109 ± 6.44 ×108 (SEM) during 29 days, 
corresponding to the same TCPS passages.  
PDMS substrates showed lower CPD compared with TCPS which means that during the same passages 
the population doubled fewer times. The GT for both substrates seemed to suffer an increase after 
passage 3. However, on PDMS, it was observed a tendency to increase from this point until P6. This 
means that the time between two cell doublings increased for cells cultured on the referred substrate 
and suggests that soft substrates may influence cell proliferation.  
Although both substrates achieved a clinically relevant number of cells (superior to 1 × 109), PDMS 
substrates presented a lower value for this parameter. For all the evaluated parameters, a statistical 
analysis was performed by Mann-Whitney test using the software GraphPad Prism 6. Data were 
compared regarding that biological variability was included, since cells were from 4 different donors. 
Besides that, a comparison between conditions (distinct substrate) was performed for all growth kinetics 
parameters and the only statistically significant difference (*P<0.05) observed was the TNC of PDMS and 
TCPS at passage 2 (Figure 9.D).  
3.5. Multiplex cytokine analysis 
To investigate whether differences were observed in the cytokine secretory profile of MSCs when 
substrate composition changed, an antibody-based multiplex cytokine assay was performed. Cells were 
cultured on TCPS or 40:1 substrates for approximately 14 days. Then, cells were maintained on the same 
substrates for 48 hours in serum-free medium and the respective conditioned media were analyzed. 
Different cytokines were evaluated and the results are shown in Figures 10-12. Regarding the raw data 
(pg/mL), results suggest a tendency for the decrease of IL-8, TNF-α, IL-6 and IL-4 secretion when cells 
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were cultured on softer substrates (40:1 PDMS), as compared to stiff TCPS. However, only IL-6 secretion 
decreased significantly (Figure 10).  
Figure 10. Evaluation of cytokine secretion by MSCs cultured on distinct substrates. Graphics represent 
cytokine concentration (pg/mL) quantified in media conditioned by MSCs maintained during 48h in 
serum-free medium on TCPS or 40:1 PDMS substrates, as indicated. Analysis was performed for (A) IL-8, 
(B) TNF-α, (C) IL-6 and (D) IL-4. Bars represent mean ± SEM of at least three independent experiments
using cells obtained from different donors. Statistical analysis was performed by Mann-Whitney test
using the software GraphPad Prism 6. Statistically significant differences are indicated (*P<0.05 ).
In Figure 11.A is represented the final total cytosolic protein concentration after cells were cultured on 
40:1 PDMS and TCPS substrates for 48 hour in serum free medium. As it is observed, there are no 
significant differences in protein concentration (mg/mL) obtained from cells maintained on the distinct 
substrates. The total protein quantification was used as a normalization factor of cellular content to 
more accurately compare MSCs cytokine secretion profile on both substrates. Similar to what was 
observed before (Figure 10), the normalized results showed a tendency for decreased secretion of all 
evaluated cytokines (IL-8, TNF-α, IL-6 and IL-4) when cells were cultured on softer 40:1 PDMS substrates 
(Figure 11 B-E). Nevertheless, the differences observed were not statistically significant. 
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Figure 11. Evaluation of cytokine secretion by MSCs cultured on distinct substrates normalized to the 
final cellular cytosolic protein content. (A) Quantification of protein concentration (mg/mL) obtained 
from cells maintained on TCPS or 40:1 PDMS substrates. Protein quantification was performed by 
Direct Detect system. Bar represent mean ± SEM of cytosolic protein content from cells obtained from 
at least three independent samples. (B)-(E) Graphics represent cytokine concentration (pg/mL) 
quantified in media conditioned by MSCs maintained during 48h in serum-free medium on TCPS or 
40:1 PDMS substrates, as indicated. Analysis was performed for (A) IL-8, (B) TNF-α, (C) IL-6 and (D) IL-4. 
Bars represent mean ± SEM of at least three independent experiments using cells obtained from 
different donors. Statistical analysis was performed by Mann-Whitney test using the software 
GraphPad Prism 6. Statistically significant differences are indicated (*P<0.05 ). 
In order to reduce variability introduced by the fact that independent umbilical cord samples were 
used 
in this study, implying higher biological variation, cytokine secretion data obtained from cells 
cultured 
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on 40:1 substrates was divided by each respective control (TCPS). This normalization step revealed a 
significant decrease of IL-6 and TNF-α secretion by cells cultured on 40:1 PDMS substrates (Figure 12). 
No other significant differences were found. 
Figure 12. Fold change (relative to TCPS) of cytokine secretion (normalized to total cytosolic protein 
content) by MSCs cultured on 40:1 PDMS substrates. Graphics represent cytokine concentration (pg/
mL) quantified in media conditioned by MSCs maintained during 48h in serum-free medium on TCPS or 
40:1 PDMS substrates, as indicated. Analysis was performed for (A) IL-8, (B) TNF-α, (C) IL-6 and (D) IL-4. 
Bars represent mean ± SEM of at least three independent experiments using cells obtained from 
different donors. Statistical analysis was performed by Mann-Whitney test using the software 
GraphPad Prism 6. Statistically significant differences are indicated (*P<0.05 ).
3.6. SECRETOME AND SUBPROTEOME ANALYSIS 
This study aimed to understand how substrate characteristics could influence Mesenchymal stem cell 
subproteomes (secretome, soluble and membrane proteomes). MSCs were maintained in culture as 
described (2.8.1) on two distinct substrates – TCPS representing a standard condition, and 40:1 PDMS 
substrates representing a biochemically and mechanically distinct culture condition. Conditioned media 
41 
obtained from cells on culture conditions were collected and concentrated as indicated (2.8.1). At the 
same time, subproteome fractionation was performed in order to study the influence of substrate 
composition in the different cell compartments—cytosol and membrane.  
3.6.1 GENE ONTOLOGY ENRICHMENT ANALYSIS 
In order to understand the protein profile of each fraction (Secretome, Membrane and Soluble 
fractions), a gene ontology (GO) analysis of cellular components was performed. For that, proteins 
identified in cells cultured on the TCPS and 40:1 PDMS substrates were combined and then compared 
with the total number of proteins found in the study.  
Regarding the cellular component analysis, the results (Figures 13-15) confirmed that there was an 
enrichment of proteins bellonging to the secretome, cytosolic and membrane fractions of the cell, in 
their respective fractions. Figures 13-15 can be appreciated in more detail in the Supplementary data 
section (Figures S1-S3). Regarding the sub-cellular component analysis in more detail, results indicate 
that in the secretome fraction (the conditioned media of cells containing molecules secreted by MSCs) 
there was an enrichment of proteins that correspond to the extracellular region of the cell, as expected 
(Figure 13). Concerning samples that were obtained from the soluble fraction of the subproteome 
fractionation procedure, it was expected that an enrichment of proteins that belong cytosolic part of the 
cell occurred. The GO analysis confirmed an enrichment of this fraction in soluble proteins corresponding 
to the cytosolic region, with a p-value<10-9, as represented (Figure 14). 
Finally, the results also allowed to prove that samples obtained from the membrane-rich subcellular 
fraction were in fact enriched with proteins belonging to membrane region of the cell. More specifically, 
proteins were grouped in categories such as cell-substrate adhesion, focal adhesion and intrinsic 
component of membrane. This information is represented in red (Figure 15) with a p-value<10-9.  
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Figure 13. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular 
component level of the proteins identified in the Secretome fraction. The proteins identified in the 
secretome fraction were highly enriched in proteins belonging to the extracellular region, as 
demonstrated by the p-values <10-9 (in red), using the web-based application Gene Ontology 
enRIchment anaLysis and visuaLizAtion tool – GOrilla 
Extracellular 
Region 
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Figure 14. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular component 
level of the proteins identified in the Cytosolic fraction. The proteins that showed higher enrichment were 
related to the extracellular region part and cytosolic part of the cell, demonstrated by a                                 p-
value<10-9, using the web-based application Gene Ontology enRIchment anaLysis and visuaLizAtion tool 
– Gorilla.
Figure 15. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular component 
level of the proteins identified in the in membrane fraction. The proteins belonging to the membrane 
region were the ones with higher enrichment, demonstrated by a p-value<10-9, using the web-based 
application Gene Ontology enRIchment anaLysis and visuaLizAtion tool – Gorilla. 
Cytosolic Region 
Membrane 
Region 
Membrane 
Region 
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3.6.2. PROTEIN IDENTIFICATION 
After verifying the fraction enrichment by gene ontology, a step of identification of proteins was 
performed. The total number of identified proteins in each cellular fraction was found and compared 
within both substrates under analysis (TCPS and 40:1 PDMS) in order to clarify whether the proteins 
were unique or shared by cells cultured on the distinct substrates. This comparison is depicted below 
(Figure 16) for all distinct fractions: secretome, soluble and membrane.  
Figure 16. Venn diagrams illustrating the total number of proteins and the number of unique and 
shared proteins by cells cultured on distinct substrates (TCPS and 40:1 substrates). (A) Number of 
proteins of MSCs secretome; (B) Number of proteins of MSCs soluble fraction (cytosol); (C) Number of 
proteins of MSCs Membrane Fraction. Percentage numbers (71%, 70% and 66%) represent 
common proteins between both substrates. 
The total number of identified proteins on each fraction ranged from 796 to 1125 (information 
available on digital format), whose highest value corresponds to membrane fraction identified 
proteins. Regarding the comparison between TCPS and 40:1 PDMS substrates, the protein 
identification revealed a similar number of identified proteins in all fractions and the majority of the 
proteins were common (66-71%) between both substrates, justifying the use of a quantitative 
method. In general, there was a slightly 
A. Secretome B. Soluble Fraction C. Membrane Fraction
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increased number of unique proteins for cells cultured on TCPS, except in the soluble fraction (Figure 
16.B) that showed a higher number of unique proteins on cells cultured on PDMS. More specifically, at 
the level of the secretome (Figure 16.A)  a total of 896 proteins were found and within these, 634 were 
common for both distinct substrates (TCPS and 40:1 PDMS), which represent 71% of the total number 
of proteins and 120-140 proteins appeared to be exclusively secreted by cells cultured on a particular 
substrate.  
Soluble Fraction presented a total number of 796 identified proteins from which 558 (70%) were 
common to both substrates and 173 were only found in cells cultured on 40:1 PDMS substrates. In 
contrast, a lower number of unique proteins were identified in cells cultured on TCPS (65). Membrane 
Fraction results (Figure 16.C) showed the identification of 1125 proteins, among which 744 (66%) were 
common between both substrates. A total of 880-990 proteins were found on each substrate and 137 
proteins appeared exclusively on cells cultured on 40:1 PDMS substrates, while cells cultured on TCPS 
exhibited 244 unique proteins.  
3.6.3. QUANTIFICATION OF PROTEINS OF ENRICHED FRACTIONS 
Since the majority of proteins were common between substrates, proteins were quantified in order to 
detect alterations on protein levels.  
Three independent umbilical cord samples were used, so in order to reduce the impact of biological 
variability, the data were analyzed through ratio of the protein levels of PDMS over TCPS (PDMS/TCPS) 
for each sample. Protein quantification (information available on digital format) revealed a total number 
of 635 proteins in the secretome, 633 for cytosolic fraction and 624 in case of membrane fraction. To 
identify the differences in the three types of sub-cellular proteomics profiles induced by the distinct 
substrates (TCPS and 40:1 PDMS), only the proteins with coefficient of variation (CV) below 30% 
(between independent samples) were used for statistical analysis. Thus, 253 proteins were found to have 
CV<30% for the secretome, while cytosolic and membrane fractions exhibited 356 and 227 proteins, 
respectively. From each cellular fraction, 79, 60 and 62 proteins (respectively) showed a p-value lower 
than 0.05 when comparing the quantitative data between cells cultured on PDMS 40:1 and TCPS, as 
summarized in Table 3. 
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Table 3. Comparison between the total number of proteins, number of proteins with CV<30% (within 
biological samples) and number of proteins with p-value<0.05 (between 40:1 PDMS and TCPS) in each 
cell fraction (secretome, cytosol and membrane). 
Cell Fraction Total Number 
 of Proteins 
Proteins with 
CV<30% 
Proteins with 
p-value<0.05
Secretome 635 253 79 
Soluble (cytosol) 633 356 60 
Membrane 624 227 62 
Within the proteins with p-value<0.05 for each enriched fraction, it was observed that some were down-
regulated and others up-regulated when comparing cells cultured on 40:1 PDMS substrates relative to 
those on TCPS. Volcano plots represent whether proteins showed statistically significant differences 
among PDMS and TCPS substrates, for each enriched fraction. Moreover, the graphs also illustrate 
whether the proteins were up- or down-regulated on PDMS in comparison with TCPS (Figure 17. A-C).  
In order to aid volcano plots interpretation, Table 4 contains the number of proteins varying on PMDS 
relative to TCPS, as well as how many were up- or down-regulated.  
Table 4. Number of protein with significant variation (p-value<0.05). Number of proteins varying in 
each fraction, including number of up- and down-regulated proteins.  
Cell Fraction proteins with 
p-value <0.05
up-regulated 
proteins 
down-regulated 
proteins 
Secretome 79 27 52 
Soluble (cytosol) 60 27 33 
Membrane 62 19 43 
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Figure 17. Volcano plots illustrating significant differences between proteins found in cells cultured 
on 40:1 PDMS substrates relative to TCPS. (A) Proteins respective to secretome; (B) proteins of soluble 
(cytosolic) fraction and (C) proteins of membrane fraction. (A), (B) and (C): Statistically significant 
differences are represented by blue plots, with a p-value<0.05. Green plots represent proteins that did 
not show significant differences relatively to TCPS (p-value>0.05).  
Regarding the results, it was observed that the number of proteins found to vary within 3 analyzed 
fractions was 60-79, where the secretome showed a higher number of proteins varying on PDMS-
cultured cells. In general, all three fractions presented an increased number of down-regulated than up-
regulated proteins. Specifically, secretome showed 52 down-regulated and 27 up-regulated proteins; 
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soluble fraction appeared with 33 down-regulated and 27 up-regulated proteins and in membrane 
fraction were detected 43 down-regulated and 19 up-regulated proteins. 
In order to understand how the referred proteins were assembled in terms of biological processes, a 
Gene Ontology analysis was used at the level of biological processes (Figure 18) and molecular functions 
(Figure 19), and the results are depicted on PANTHER software charts.  
Figure 18. Pie charts illustrating the biological processes concerning the proteins up-regulated in cells 
cultured on 40:1 PDMS relative to TCPS, within each cellular fraction. (A) Secretome; (B) Soluble Fraction; 
(C) Membrane.
Regarding the pie charts (Figure 18), it was clear that all of the 3 fractions showed a higher number of 
proteins involved in metabolic processes and cellular responses. The majority of the proteins within 
metabolic processes were related with primary metabolic processes. Cellular responses were related to 
cell communication, more specifically to cell-cell signaling. Among up-regulated proteins, some of them 
seemed to be related with cytoskeleton reorganization, more evidenced in soluble and membrane 
fraction.  
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Regarding the molecular function results (Figure 19), proteins that were differentially expressed in the 
secretome, soluble and membrane fractions seemed to have common catalytic activity and to be 
involved in binding. Focusing on the secretome and soluble fractions, the majority of proteins had 
catalytic activity. Proteins belonging to this category seemed to have mainly oxireductase activity. 
Membrane fraction showed an increased number of proteins involved in structural molecule activity and 
transporter activity when compared with other fractions, which seems to be consistent with the 
expected functions of membrane-related proteins. Antioxidant activity is commonly represented in 
three fractions and it is related with peroxidase activity.  
Figure 19. Pie charts illustrating the molecular functions of the proteins up-regulated in cells cultured 
on 40:1 PDMS relative to TCPS, within each cellular fraction. (A) Secretome; (B) Soluble 
Fraction; (C) Membrane. 
Within all the up-regulated proteins, the one that showed the highest value of fold change 
was Superoxide Dismutase [Mn] (mitochondrial), which presented an up-regulation of approximately 9 
fold 
Antioxidant activity 
Binding 
Catalytic activity 
Enzyme regulator activity 
Receptor activity 
Structural molecule activity 
Transporter activity  
50 
in secretome. Antioxidant activity was also evaluated in the remaining fractions and a total of 6 proteins 
related to this function were found (Table 5).  
Table 5. Proteins with antioxidant activity found in secretome, soluble and membrane fraction. 
Protein Name Fraction Mean SD %CV p-value
1. Peroxiredoxin-1 Soluble 
fraction 
1.27 0.012 1 0.001 
2. Peroxiredoxin-5, mitochondrial Membrane 1.89 0.261 14 0.028 
3. Microsomal glutathione S-transferase 3 Membrane 1.904 0.339 18 0.044 
4. Thioredoxin reductase 1, cytoplasmic Secretome 2.231 0.46 21 0.044 
5. Thioredoxin-dependent peroxide 
reductase, mitochondrial 
Secretome 3.104 0.615 20 0.027 
6. Superoxide dismutase [Mn], 
mitochondrial 
Secretome 9.143 1.012 11 0.005 
These results suggest that MSCs cultured on 40:1 PDMS substrates possess a higher anti-oxidant capacity 
than their counterparts cultured on TCPS. This observation is important, since one of the major features 
commonly attributed to MSCs is precisely their anti-oxidant and protective capacity in several biological 
contexts.
CHAPTER 4 
DISCUSSION
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4. DISCUSSION
MSCs are an exciting cell-based therapeutic candidate for use in regenerative medicine. Within MSCs 
based populations, WJ’s cells have been described as an attractive population for cell therapy due to 
their characteristics such as trilineage mesodermal potential of differentiation, immune modulatory 
responses and due to the variety of secreted molecules with trophic activity. Additionally, these cells are 
obtained from an extraembryonic tissue at the time of birth, which suggests the existence of less genetic 
mutations when compared with cells from adult tissues15.  
The extracellular matrix (ECM), a major element of the extracellular niche, provides not only a scaffold 
for cellular support, migration and proliferation, but also acts as the surrounding microenvironment that 
influences growth, function and eventually fate of the cell by presenting biochemical and mechanical 
cues as well as binding soluble factors. Based on the literature, it is known that cells sense external 
mechanical stimuli through mechanotransduction mechanisms, translating biophysical cues into 
physiological responses 26,28,57. The response can be at the level of morphology, proliferation, protein 
synthesis or even differentiation58. The current study presented an approach to understand the 
influence of biochemical and mechanical properties of ECM-like substrates over MSCs cultured in vitro 
and whether such elements influence their secretory profile and subcellular proteome. 
To that end, MSCs were isolated from umbilical cord matrix – Wharton’s Jelly (WJ) – and cultured on 
substrates with different characteristics, namely stiffness and ECM proteins. 
Cells were cultured on tissue culture plates (TCPS) whose stiffness was at the level of GPa (gigapascal) 
and, on the other hand, on 40:1 PDMS substrates representing a softer culture condition with a 
described stiffness ranging between 30 to 40 kPa (KiloPascal)59. During this study it was not possible to 
directly determine the stiffness of the substrates, since the available methods (namely rheometry) 
required that the substrates were detached from the casting plates where they were produced, which 
in this case was not possible without compromising its elastic properties due to the very low stiffness of 
the material. Additionally, PDMS hydrogels were covalently conjugated with extracellular matrix 
proteins, namely Fibronectin (FN) and collagen type-I, that allowed cell adhesion to the substrates, which 
otherwise would not occur. 
Regarding the isolation of WJ-MSCs, umbilical cord fragments exhibited the first cells migrating after 
around 10 days in TCPS, while on PDMS (40:1) the first cells only started migrating after 15 days [Figure 
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7. (A), (C),(E)]. The isolation of MSCs on PDMS substrates was typically more difficult to achieve than on
TCPS, which could be related with the described lower migration and proliferation capacity that cells 
demonstrate when cultured on soft substrates34,42. Nevertheless, to our best knowledge, the isolation of 
WJ-MSCs was never reported using soft substrates as described here. For reasons related to 
experimental reproducibility and to ensure that the original cell population to be tested using distinct 
experimental conditions (i.e.: MSCs cultured on PDMS or TCPS) were homogeneous, the cells used for 
all the studies presented here were isolated on TCPS and then cultured on PDMS or TCPS from passage 
2 (P2) onwards.  
A previous immunophenotypic characterization revealed that the populations of cells isolated from 3 
independent human umbilical cords could be considered MSCs and, according to Internal Society for 
Cellular Therapy22,23 these cells also shared all minimal criteria used to define MSCs. 
A kinetics proliferation study (Figure 9) was performed in order to elucidate about the proliferation 
potential of MSCs. Several parameters were evaluated for both substrates (TCPS or 40:1 PDMS): the total 
number of cells (Figure 9.D) — i.e., total number of cells that could be obtained if no cells were discarded 
during the analyzed passages — (TNC), population doubling (PD) rate (Figure 9.A) between each passage, 
and generation time (GT) (Figure 9.C) that represented the average time between two cell doublings. 
The TNC obtained from passage 2 (P2) to passage 6 (26 days) on TCPS (1.61 × 1010 ± 1.12 × 1010) was 
higher when compared with PDMS (1.37 × 109 ± 6.44 × 108), as well as cumulative population doubling 
(CPD) (Figure 9.B), which indicates how many times the population doubled (9.81 ± 1.58 for TCPS and 
6.68 ±1.48 for PDMS). Despite this lower proliferative profile of MSCs cultured on 40:1 PDMS substrates 
when compared to TCPS, there were no statistically significant differences, except for the total number 
of cells in P2. Taken together, these results are somehow in agreement with previous studies showing 
that mammalian cell proliferation increased on substrates with higher rigidity, where the development 
of force-driven focal adhesions was enhanced, which lead to higher levels of FAK (focal adhesion kinase) 
phosphorylation, which in turn activate signaling pathways known to promote cell proliferation28.  
After cell culture conditions were well defined on both substrates (40:1 PDMS and TCPS), two different 
approaches were used in order to study MSCs secretome. A direct evaluation of cytokine secretion was 
performed using multiplex-cytokine analysis and only secretion of IL-6 and TNF-α revealed significant 
when cells were cultured on soft substrates (40:1 PDMS).  
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An unbiased analysis of the secretome and the subcellular fractions were performed by Mass 
Spectrometry (MS) in order to obtain the secretory and subproteomic profiles of MSCs cultured on 
substrates with distinct mechanical and biochemical properties.  
 After protein identification by Mass Spectrometry analysis, a gene ontology analysis of cellular 
components was performed to understand the protein profile obtained in each fraction (Secretome, 
Membrane and Soluble). For that, the proteins identified on the aforementioned fractions from cells 
cultured on TCPS or 40:1 PDMS were combined and then compared with the total number of proteins 
found in the study. Regarding the cellular component analysis, the results showed that there was an 
enrichment of proteins bellonging to cytosolic and membrane fractions of the cell, in their respective 
fractions and revealed that the majority of proteins found in the secretome belonged to the extracellular 
region. After verifying the fraction enrichment by gene ontology, a step of identification of proteins was 
performed. The total number of identified proteins in each cellular fraction was found and compared 
within both substrates under analysis (TCPS and 40:1 PDMS) in order to clarify whether the proteins 
were unique or shared by cells cultured on the distinct substrates. There were 896 proteins identified in 
MSCs secretome, 796 proteins in the soluble fraction and 1125 in the membrane fraction. The majority 
of the proteins found in each of the fractions was shared by both substrates and only in soluble fraction 
were identified more unique proteins for PDMS than for TCPS. Since the objective was to study the 
influence of substrate composition on the protein profile of secretome, soluble and membrane fractions, 
proteins were quantified to identify consequent alterations. SWATH analysis revealed a variation on 
secreted proteins by cells cultured on 40:1 PDMS substrates relative to those cultured on TCPS. In a total 
of 635 proteins, 79 showed statistically significant differences. The same was verified for the cellular 
subproteomes: the expression of 60 proteins varied in the soluble fraction and 62 varied in the 
membrane fraction. In general, all three fractions presented a higher number of down-regulated 
proteins than up-regulated proteins.  
Within all the up-regulated proteins, the one that showed the highest value of fold change was 
Superoxide Dismutase [Mn] (mitochondrial), which presented an up-regulation of approximately 9 fold 
in the secretome. From this point, the presence of other antioxidant proteins was evaluated in all the 
fractions, since there was previous evidence that stem and progenitor cells can protect other cells from 
damaging oxygen free radicals through the production of antioxidants and anti-apoptotic molecules60. A 
total of 6 proteins with antioxidant activity were found: Peroxiredoxin-1 in the soluble fraction; 
Peroxiredoxin-5 (mitochondrial) and Microsomal glutathione S-transferase 3 in the membrane fraction; 
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Thioredoxin reductase 1 (cytoplasmic), Thioredoxin-dependent peroxide reductase (mitochondrial) and 
Superoxide dismutase [Mn] (mitochondrial) in the secretome. 
The therapeutic potential of the secretome of mesenchymal stem cell has been reported with various 
types of disease models. Recently, the therapeutic effect of UC-MSCs secretome showed to play a 
protective role in muscle atrophied cells by blocking the oxidative stress generated by the increased 
reactive oxygen species (ROS). Additionally, MSCs secretome demonstrated to protect cells from 
apoptosis, which occurs following ROS generation in the mechanism of muscle atrophy. According to 
that, when muscle atrophied cells were in contact with MSCs secretome, a downregulation of oxidative 
stress and upregulation of antioxidant enzymes that may be beneficial to the protection of muscle mass 
occurred61.  
Despite the advantages of MSCs that make them suitable for cell therapy purposes, their therapeutic 
application has been limited due to their susceptibility to several stresses to which they are exposed 
during their preparation and following transplantation. Occasionally, the hostile environment that 
transplanted cells encounter in the host organism does not allow cell survival62. We propose tha MSCs 
cultured on soft substrates may constitute a population of cells with increased antioxidant properties, in 
principle allowing the cells to cope better with these stressful and hostile environments that they may 
encouter in vivo. 
According to the literature, MSCs secretome includes cytokines, chemokines and growth factors and has 
gained increasing attention regarding its multiple implications for the repair, restoration or regeneration 
of injured tissues. Hence, it has been proposed that the injection of secreted molecules could be useful, 
rather than implanting the cells, for example for brain repair63. 
This work provides an important insight into how distinct culture substrates and conditions might be 
useful to modulate the phenotype of MSCs, turning these cells more suitable for specific tailor-made 
clinical or biotechnological purposes. It provides a large body of data that, for the purpose of the current 
thesis, was only detailed for a few illustrative proteins identified, in this case related with the already 
known important antioxidant activity of MSCs.
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5. CONCLUSION
With the present work it was possible to develop a soft substrate (40:1 PDMS) for the isolation and 
culture of MSCs without significant differences on proliferation kinetics in comparison with TCPS. On the 
other hand, this substrate seems to modulate MSCs protein profile at the level of secretome, soluble 
(cytosolic) and membrane fractions. This insight is based on a variation on protein levels that 
demonstrated the up-regulation of several proteins identified in this study. Some of these proteins are 
involved in metabolic processes and cellular responses related with antioxidant activity of MSCs. This 
work suggests that mechanotransduction may have a role in the modulation of mesenchymal stem cells’ 
secretome and other subproteomes of the cell (namely cytosolic- and membrane-related) and according 
to our data may enhance the antioxidant activity of MSCs.
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7. SUPPLEMENTARY DATA
Table 1. SWATH-MS setup. 
m/z range Width (Da) 
Window 1 349.5-365.8 16.3 
Window 2 364.8-379.3 14.5 
Window 3 378.3-390.5 12.2 
Window 4 389.5-400.4 10.9 
Window 5 399.4-409.4 10 
Window 6 408.4-418.4 10 
Window 7 417.4-427 9.6 
Window 8 426-435.5 9.5 
Window 9 434.5-444.1 9.6 
Window 10 443.1-452.2 9.1 
Window 11 451.2-459.8 8.6 
Window 12 458.8-467.5 8.7 
Window 13 466.5-475.1 8.6 
Window 14 474.1-482.3 8.2 
Window 15 481.3-490 8.7 
Window 16 489-497.2 8.2 
Window 17 496.2-503.9 7.7 
Window 18 502.9-511.1 8.2 
Window 19 510.1-518.3 8.2 
Window 20 517.3-525.5 8.2 
Window 21 524.5-532.7 8.2 
Window 22 531.7-539.9 8.2 
Window 23 538.9-547.6 8.7 
Window 24 546.6-554.8 8.2 
Window 25 553.8-562 8.2 
Window 26 561-569.2 8.2 
Window 27 568.2-576.9 8.7 
Window 28 575.9-584.1 8.2 
Window 29 583.1-592.2 9.1 
Window 30 591.2-600.3 9.1 
Window 31 599.3-607.9 8.6 
Window 32 606.9-616 9.1 
Window 33 615-624.6 9.6 
Window 34 623.6-632.7 9.1 
Window 35 631.7-640.8 9.1 
Window 36 639.8-649.3 9.5 
Window 37 648.3-658.3 10 
Window 38 657.3-667.3 10 
Window 39 666.3-676.8 10.5 
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Window 40 675.8-686.7 10.9 
Window 41 685.7-697.5 11.8 
Window 42 696.5-709.2 12.7 
Window 43 708.2-720.9 12.7 
Window 44 719.9-732.1 12.2 
Window 45 731.1-743.4 12.3 
Window 46 742.4-755.5 13.1 
Window 47 754.5-767.7 13.2 
Window 48 766.7-780.3 13.6 
Window 49 779.3-793.8 14.5 
Window 50 792.8-808.2 15.4 
Window 51 807.2-823.9 16.7 
Window 52 822.9-841.9 19 
Window 53 840.9-863.1 22.2 
Window 54 862.1-885.6 23.5 
Window 55 884.6-910.8 26.2 
Window 56 909.8-942.7 32.9 
Window 57 941.7-985 43.3 
Window 58 984-1036.3 52.3 
Window 59 1035.3-1109.7 74.4 
Window 60 1108.7-1249.6 140.9 
7
3
 
Figure S1. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular component level of the proteins identified in the in Secretome. The 
proteins belonging to the extracellular region part were the ones with higher enrichment, demonstrated by a p-value<10-9, using the web-based application Gene 
Ontology enRIchment anaLysis and visuaLizAtion tool – Gorilla. 
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Figure S2. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular component level of the proteins identified in the Cytosolic fraction. The 
proteins belonging to the extracellular region part were the ones with higher enrichment, demonstrated by a p-value<10-9, using the web-based application Gene 
Ontology enRIchment anaLysis and visuaLizAtion tool – Gorilla 
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Figure S3. Diagram representing the Gene Ontology (GO) Enrichment analysis at the cellular component level of the proteins identified in the membrane fraction. 
The proteins belonging to the membrane region were the ones with higher enrichment, demonstrated by a p-value<10-9, using the web-based application Gene 
Ontology enRIchment anaLysis and visuaLizAtion tool –Gorilla 
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